Advertisement
Screener

REPLIGEN CORP (RGEN) ROA

REPLIGEN CORP ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • REPLIGEN CORP roa for the quarter ending 2026-06-30 was 1.41%, a change of 1.88% year-over-year.
  • REPLIGEN CORP roa for the quarter ending 2026-03-31 was 1.75%, a change of 2.56% year-over-year.
  • REPLIGEN CORP roa for the quarter ending 2025-12-31 was 1.66%, a change of 2.56% year-over-year.
  • REPLIGEN CORP roa for the quarter ending 2025-09-30 was 0.06%, a change of 0.35% year-over-year.
  • REPLIGEN CORP roa for fiscal 2025 was 1.66%, a change of 2.56% from fiscal 2024.
  • REPLIGEN CORP roa for fiscal 2024 was -0.90%, a 171.72% decline from fiscal 2023.
  • REPLIGEN CORP roa for fiscal 2023 was 1.26%, a 82.88% decline from fiscal 2022.
  • REPLIGEN CORP roa for fiscal 2022 was 7.35%, a 35.03% increase from fiscal 2021.
Available history
2011-03-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-301.41%$41.54M$5.01M$2.95B
2026-03-311.75%$51.4M$8.33M$2.93B
2025-12-311.66%$48.89M$13.29M$2.95B
2025-09-300.06%$1.74M$14.91M$2.92B
2025-06-30-0.48%-$13.83M$14.87M$2.9B
2025-03-31-0.81%-$22.98M$5.83M$2.85B
2024-12-31-0.90%-$25.51M-$33.87M$2.83B
2024-09-30-0.29%-$8.1M-$654.00K$2.83B
2024-06-300.33%$9.48M$5.71M$2.87B
2024-03-310.83%$23.56M$3.30M$2.85B
2023-12-311.26%$35.6M-$16.45M$2.83B
2023-09-303.99%$100.78M$16.92M$2.52B
2023-06-304.86%$124.26M$19.79M$2.56B
2023-03-316.06%$154.33M$15.34M$2.55B
2022-12-317.35%$185.96M$48.73M$2.53B
2022-09-306.75%$166.34M$40.41M$2.46B
2022-06-306.52%$159.43M$49.86M$2.44B
2022-03-316.12%$145.81M$46.96M$2.38B
2021-12-315.44%$128.29M$29.11M$2.36B
2021-09-305.30%$118.88M$33.50M$2.24B
2021-06-304.96%$99.93M$36.23M$2.02B
2021-03-314.13%$79.56M$29.45M$1.93B
2020-12-313.15%$59.93M$19.70M$1.9B
2020-09-302.97%$43.83M$14.55M$1.48B
2020-06-302.15%$30.94M$15.86M$1.44B
2020-03-311.65%$23.17M$9.81M$1.41B
2019-12-311.53%$21.41M$3.60M$1.4B
2019-09-301.70%$23.45M$1.66M$1.38B
2019-06-302.49%$26.58M$8.10M$1.07B
2019-03-312.66%$21.22M$8.05M$797.92M
2018-12-312.15%$16.62M$5.64M$774.62M
2018-09-303.04%$23.16M$4.79M$762.13M
2018-06-303.09%$23.03M$2.74M$745.08M
2018-03-313.87%$28.73M$3.45M$743.25M
2017-12-313.81%$28.35M$12.18M$743.52M
2017-09-302.89%$21.21M$4.67M$734.24M
2017-06-305.73%$17.69M$8.44M$308.76M
2017-03-314.52%$13.13M$3.07M$290.63M
2016-12-314.04%$11.68M$5.03M$288.91M
2016-09-302.43%$6.92M$1.16M$285.05M
2016-06-302.94%$8.3M$3.87M$282.31M
2016-03-315.46%$8.04M$1.63M$147.32M
2015-12-316.39%$9.35M$265.00K$146.24M
2015-09-306.21%$8.68M$2.54M$139.85M
2015-06-305.54%$7.61M$3.61M$137.34M
2015-03-315.31%$6.82M$2.93M$128.58M
2014-12-316.37%$8.17M-$398.00K$128.29M
2014-09-309.23%$11.9M$1.47M$128.83M
2014-06-3012.64%$16.32M$2.83M$129.05M
2014-03-3115.11%$18.03M$4.28M$119.33M
2013-12-3113.56%$16.09M$3.33M$118.64M
2013-09-3019.99%$22.32M$5.89M$111.64M
2013-06-3017.43%$18.24M$4.54M$104.65M
2013-03-3115.69%$15.27M$2.34M$97.31M
2012-12-3114.59%$14.16M$9.55M$97.01M
2012-09-305.27%$4.47M$1.81M$84.9M
2012-06-304.01%$3.27M$1.57M$81.45M
2012-03-312.05%$1.64M$1.23M$80.39M
2011-12-31-2.12%-$1.61M-$2.16M$76.06M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-311.66%$48.89M$2.95B
2024-12-31-0.90%-$25.51M$2.83B
2023-12-311.26%$35.6M$2.83B
2022-12-317.35%$185.96M$2.53B
2021-12-315.44%$128.29M$2.36B
2020-12-313.15%$59.93M$1.9B
2019-12-311.53%$21.41M$1.4B
2018-12-312.15%$16.62M$774.62M
2017-12-313.81%$28.35M$743.52M
2016-12-314.04%$11.68M$288.91M
2015-12-316.39%$9.35M$146.24M
2014-12-316.37%$8.17M$128.29M
2013-12-3113.56%$16.09M$118.64M
2012-12-3114.59%$14.16M$97.01M
2011-12-31-2.12%-$1.61M$76.06M
2011-03-31-0.06%-$43,509.00$72.29M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78